Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

16% of people believe they have developed a medical condition since the coronavirus crisis started but have not seen a doctor because they worry about getting COVID-19
News | Coronavirus (COVID-19)
Study Shows Decline in Medical Visits Due to COVID-19 Fear

December 7, 2020 — New research* from Zegami, an Oxford based medical image analysis platform, reveals that 29% of ...

Time December 07, 2020
arrow
A new hybrid X-ray detector developed by the University of Surrey outperforms commercial devices — and could lead to more accurate cancer therapy.
News | X-Ray
New Hybrid X-ray Detector Goes Toe-to-toe with State-of-the-art Rivals

December 3, 2020 — A new hybrid X-ray detector developed by the University of Surrey outperforms commercial devices — ...

Time December 03, 2020
arrow
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
News | Prostate Cancer
Radiation Therapy Has the Greatest Impact on Patient Finances

December 2, 2020 — For men with early-stage prostate cancer, choices about initial treatment carry varying risks of ...

Time December 02, 2020
arrow
Sponsored Content | Sponsored Content | Videos | Information Technology
Talking Trends with Elekta

Treating cancer effectively often includes a combination of patient therapies. In recent years, technology advancements ...

Time December 01, 2020
arrow
 Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that their manufacturing partner Nucleis (Liege, Belgium) has manufactured and shipped their first patient doses of rhPSMA-7.3 (18F), an investigational Prostate-Specific Membrane Antigen (PSMA)-targeted radiohybrid PET imaging agent, currently under evaluation in clinical trials in men with newly diagnosed prostate cancer and suspected prostate cancer recurrence.
News | PET Imaging
Blue Earth Diagnostics Announces First Patient Doses of PET Imaging Agent in Collaboration with Nucleis Radiopharmaceuticals

November 25, 2020 — Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that their ...

Time November 25, 2020
arrow
GE Healthcare invests in a unique approach to cutting-edge CT technology and acquires Prismatic Sensors AB, a leader in Deep Silicon detector technology for photon counting computed tomography (PCCT)
News | Computed Tomography (CT)
GE Healthcare Pioneers Photon Counting CT with Prismatic Sensors Acquisition

November 25, 2020 — GE Healthcare today announced its acquisition of Prismatic Sensors AB, a Swedish start-up ...

Time November 25, 2020
arrow
 MIM Software Inc. announced a collaboration with Peter MacCallum Cancer Centre (Peter Mac) in support of its Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) program.
News | Prostate Cancer
MIM Software Inc. Announces Collaboration with Peter MacCallum Cancer Centre to Improve Patient Management

November 19, 2020 — MIM Software Inc. announced a collaboration with Peter MacCallum Cancer Centre (Peter Mac) in ...

Time November 19, 2020
arrow
Infinitt has added a Digital Pathology Solution and a Radiation Therapy PACS to its product offerings
News | Enterprise Imaging
Infinitt Highlights Enterprise Imaging Platform with Extensive Line of Diagnostic Capabilities at RSNA 2020

November 19, 2020 — Infinitt North America, a single-source provider of enterprise imaging solutions for healthcare ...

Time November 19, 2020
arrow
During active surveillance, prostate cancer is carefully monitored for signs of progression through regular prostate-specific antigen (PSA) screening, prostate exams, imaging, and repeat biopsies.
News | Prostate Cancer
Men with Negative Biopsies During Active Surveillance Have Good Outcomes

November 18, 2020 — Can early-stage prostate cancer "vanish" during follow-up? More likely the cancer is just "hidden"- ...

Time November 18, 2020
arrow
Radiation oncologists across the country will meet virtually with members of Congress this week to discuss value-based payment, prior authorization and supporting cancer care during the pandemic
News | Radiation Oncology
Radiation Oncologists Urge Congress to Advance Bills That Protect Patient Access to Cancer Care During Pandemic

November 18, 2020 — Radiation oncologists across the country will meet virtually with members of Congress this week to ...

Time November 18, 2020
arrow
Penn study supports the use of more testicular shielding for men and children during diagnostics
News | Radiology Imaging
Diagnostic Imaging May Increase Risk of Testicular Cancer

November 16, 2020 — Early and repeated exposures to diagnostic imaging, such as X-rays and computed tomography (CT) ...

Time November 16, 2020
arrow
Videos | Radiation Therapy
VIDEO: Explaining Boron Neutron Capture Therapy for Targeted Cancer Radiotherapy

Bruce Bauer, Ph.D., CEO of TAE Life Sciences. The company is developing boron neutron capture therapy (BNCT) as a new ...

Time November 15, 2020
arrow
Minimizing delays to treatment could improve cancer survival rates, say researchers
News | Radiation Oncology
Every Month Delayed in Cancer Treatment Can Raise Risk of Death by Around 10%

November 10, 2020 — People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% higher ...

Time November 10, 2020
arrow
In this retrospective cohort study of men with low-risk prostate cancer followed up for a median of 7.6 years, African American men, compared with non-Hispanic White men, had a statistically significant increased 10-year cumulative incidence of disease progression and definitive treatment, but not metastasis or prostate cancer–specific mortality
News | Prostate Cancer
Active Surveillance Safe for African Americans with Low-risk Prostate Cancer

November 4, 2020 — Previous studies have shown that African American men are 2.4 times as likely to die from prostate ...

Time November 04, 2020
arrow
Metastasis-free survival is a strong surrogate endpoint for overall survival over biochemical failure for men receiving salvage radiotherapy for recurrent prostate cancer
News | Prostate Cancer
MFS Is a Strong Surrogate Endpoint for OS for Men Receiving Salvage RT

November 2, 2020 — An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving salvage ...

Time November 02, 2020
arrow
Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer. Image courtesy of the American College of Surgeons
News | Radiation Therapy
Some Rectal Cancer Patients Can Safely Avoid an Aggressive Operation

November 2, 2020 — A nonsurgical treatment option for rectal cancer that preserves quality of life is safe for carefully ...

Time November 02, 2020
arrow
Conceptual diagram of bio-organizational crushing technology based on high-intensity concentric ultrasonography. Image courtesy of Korea Institue of Science and Technology(KIST)
News | Ultrasound Imaging
Destroying Cancer Cells with Non-surgical Ultrasound Treatment

November 2, 2020 — Focusing ultrasound energy on a target site in the body to generate heat can burn and destroy the ...

Time November 02, 2020
arrow
Updated results of NRG Oncology trial display effectiveness of gemcitabine and daily radiation for bladder preservation in muscle-invasive bladder cancer patients
News | Radiation Oncology
Effectiveness of Gemcitabine and Daily RT for Bladder Preservation in Muscle-invasive Bladder Cancer

November 2, 2020 — Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy ...

Time November 02, 2020
arrow
Follow up results on first multicenter trial to report outcomes of salvage low dose radiotherapy brachytherapy after external beam radiotherapy for prostate cancer
News | Prostate Cancer
Outcomes of Salvage Low Dose RT Brachytherapy After EBRT for Prostate Cancer

October 30, 2020 — Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) ...

Time October 30, 2020
arrow
José Obeso, MD, PhD, (left) of of the Centro Integral de Neurociencias (HM CINAC) in Madrid and Nir Lipsman, MD, PhD, (right) of Sunnybrook Health Sciences Centre in Toronto. Each doctor is leading a clinical trial using focused ultrasound to target the striatum in patients with Parkinson's disease.
News | Focused Ultrasound Therapy
Two Landmark Studies Advance Focused Ultrasound Treatment for Parkinson's Disease

October 30, 2020 — A team of researchers in Madrid, Spain, and another team in Toronto, Canada, are the first in the ...

Time October 30, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now